Atul Limited

Atul Ltd board approved ₹167 crore capital expenditure for new MCPP-p and MCPA manufacturing facility. New capacity includes 1,000 tpa Mecoprop-p and 750 tpa 2-methyl-4-chlorophenoxyacetic acid herbic

Atul reported standalone Q1 FY27 revenue of ₹1,588.6 Cr, up 21.8% YoY, with net profit doubling to ₹201.03 Cr. Consolidated performance showed revenue of ₹1,847.95 Cr, up 25% YoY, and net profit of ₹2